Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival

International Journal of Gynecological Cancer

Volumn 13, Issue 5, 2003, Pages 633-639

  Obermair, Andreas ^a,d   Cheuk, R ^b   Horwood, K ^a   Neudorfer, M ^d   Janda, M ^c   Giannis, G ^d   Nicklin, J L ^a   Perrin, L C ^a   Crandon, A J ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Queensland Radium Institute   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anemia; Cervical cancer; Chemoradiotherapy; Prognostic factors; Treatment

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINS; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; QUEENSLAND; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 1242314294     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13395.x     Document Type: Article

References (26)

1. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
2. Spivak JL. Cancer-related anemia. its causes and characteristics. Semin Oncol 1994;21:3-8.
3. Mercadante S, Gebbia V, Marazzo A, Filosto S. Anaemia in cancer. pathophysiology and treatment. Cancer Treat Rev 2000;26:303-11.
4. Bush RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Phys 1986;12:2047-50.
5. Dische S. Radiotherapy and anaemia-the clinical experience. Radiother Oncol 1991;20(Suppl.):35-40.
6. Girinski T, Pejovic-Lenfant MH, Bourhis J et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Phys 1989;16:37-42.
7. Peters WA, Liu PY, Barrett RJ 2nd et al. Concurrent chemotherapy and pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18: 1606-13.
8. Keys HM, Bundy BN, Stehman FB et al. Cisplatin, radiation, and adjunct hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New Eng J Med 1999;340:1154-61.
9. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. New Eng J Med 1999;340:1137-43.
10. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin vesus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17: 1339-48.
11. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New Eng J Med 1999;340: 1144-53.
12. Thomas GM. Concurrent Chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000;10:44-50.
13. Obermair A, Cheuk R, Horwood K et al. Impact of hemoglobin levels before and during concurrent chemo-radiotherapy on the response of treatment in patients with cervical carcinoma: Preliminary results. Cancer 2001;92:903-8.
14. Broders AC. Squamous-cell epithelioma of the lip: a study of five hundred and thirty-seven cases. JAMA 1920;74:656-64.
15. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995;58:157-8.
16. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Statist Assoc 1985;53: 457-81.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-70.
18. Hoeckel M, Vaupel P. Tumor hypoxia. Definitions and current clinical, biologic, and molecular aspects. J Nat Cancer Inst 2001;93:266-76.
19. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-40.
20. Höckel M, Schlenger K, Höckel S, Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999;59:4525-8.
21. Henke M, Bechtold C, Momm F, Dörr W, Guttenberger R. Blood hemoglobin level may affect radiosensitivity-preliminary results on acutely reacting normal tissues. Int J Radiat Oncol Phys 2000;48:339-45.
22. Partridge SE, Aquino-Parsons C, Luo C, Green A, Olive PL. A pilot study comparing intratumoural oxygenation using the comet assay following 2.5% and 5% carbogen and 100% oxygen. Int J Radiat Oncol Biol Phys 2001;49:575-80.
23. Marinez JC, Villar A, Cabezon MA et al. Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:47-53.
24. American Association of Blood Banks. Facts about blood and blood banking. Update 2001. http://www.aabb. org/All_About_Blood/FAQs/aabb_faqs.htm#donor.
25. Blood and Organ Donation Taskforce. Department of Health and Aged Care. Fact Sheet no. 1. Updated 6 April, 2001 .http://www.health.gov.au/hsdd/bodt/ index.htm.
26. Benedet J, Odicino F, Maisonneuve P et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 1998;3:5-34.